Skip to content

Quest Diagnostics Incorporated Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 22, 2026 results vs estimates

Quest Diagnostics Incorporated · E.DGX.NYSE · United States
Use symbol E.DGX.NYSE in our API & Excel add-in to retrieve this data ↓
252.92
(+0.03%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 20.13%

Quest Diagnostics Incorporated Forecast

Quest Diagnostics Incorporated short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 20.1% a year, a typical one-standard-deviation range is 245.75–260.09 over a week, 238.23–267.61 over a month and 202.02–303.82 over a year. (Signals as of 1 Nov 2026.)

Quest Diagnostics Incorporated Price Chart

MacroFinance.ai

Quest Diagnostics Incorporated Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Quest Diagnostics Incorporated
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Quest Diagnostics Incorporated
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Quest Diagnostics Incorporated
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Quest Diagnostics Incorporated
P/E
25.09x
Stretched vs own history
QoQ −2.7%
YoY +12.5%
now 25.090420.27 low25.99 high
ⓘP/E As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Quest Diagnostics Incorporated
P/S
2.39x
Stretched vs own history
QoQ +1.0%
YoY +20.1%
now 2.39231.81 low2.46 high
ⓘP/S As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Quest Diagnostics Incorporated
P/B
3.71x
Stretched vs own history
QoQ +1.9%
YoY +24.7%
now 3.71162.71 low3.81 high
ⓘP/B As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Quest Diagnostics Incorporated
EV/EBITDA
14.68x
Stretched vs own history
QoQ −1.3%
YoY +13.9%
now 14.68311.97 low15.01 high
ⓘEV/EBITDA As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Quest Diagnostics Incorporated
EV/Sales
2.86x
Stretched vs own history
QoQ −0.3%
YoY +12.4%
now 2.85582.36 low2.92 high
ⓘEV/Sales As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Quest Diagnostics Incorporated
FCF Yield
4.9%
Weak vs own history
QoQ −1.5%
YoY −24.7%
now 4.8544.73 low7.09 high
ⓘFCF Yield As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Quest Diagnostics Incorporated
Earnings Yield
4.0%
Weak vs own history
QoQ +2.7%
YoY −11.1%
now 3.98563.85 low4.93 high
ⓘEarnings Yield As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Quest Diagnostics Incorporated
Dividend Yield
1.3%
Weak vs own history
QoQ −1.8%
YoY −18.9%
now 1.30261.27 low1.77 high
ⓘDividend Yield As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Quest Diagnostics Incorporated
Market Cap
$28.3B
Highest in 5 years
QoQ +3.5%
YoY +31.1%
now 28327.0419,638 low29,075 high
ⓘMarket Cap As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Quest Diagnostics Incorporated
Net Debt
$5.5B
Mid-range vs own history
QoQ −4.7%
YoY −7.8%
now 54885,488 low6,587 high
ⓘNet Debt As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Quest Diagnostics Incorporated
Net Debt / EBITDA
2.38x
Mid-range vs own history
QoQ −7.9%
YoY −14.4%
now 2.3832.38 low2.99 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Quest Diagnostics Incorporated
Current Ratio
1.70x
Strong vs own history
QoQ +6.9%
YoY +50.7%
now 1.69961.04 low1.7 high
ⓘCurrent Ratio As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Quest Diagnostics Incorporated
Quick Ratio
1.58x
Strong vs own history
QoQ +8.2%
YoY +51.9%
now 1.58070.96 low1.58 high
ⓘQuick Ratio As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Quest Diagnostics Incorporated
Interest Coverage
6.76x
Mid-range vs own history
QoQ +7.7%
YoY +20.9%
now 6.76385.6 low6.76 high
ⓘInterest Coverage As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Quest Diagnostics Incorporated
Debt / Equity
0.82x
Mid-range vs own history
QoQ −3.0%
YoY −6.3%
now 0.82350.82 low0.96 high
ⓘDebt / Equity As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Quest Diagnostics Incorporated
Piotroski F-Score
8
Strong vs own history
QoQ 0.0%
YoY 0.0%
now 87 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Quest Diagnostics Incorporated
Altman Z-Score
3.82
Strong vs own history
QoQ +2.2%
YoY +14.6%
now 3.81683.2 low3.87 high
ⓘAltman Z-Score As of 22 Nov 2026.See Quest Diagnostics Incorporated returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Quest Diagnostics Incorporated, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Quest Diagnostics Incorporated fundamentals: income statement, balance sheet & cash flow

Quest Diagnostics Incorporated reported revenue of $11.04bn and net income of $992.0m in FY2025, the year ended 31 December 2025 — revenue up 11.8% and net income up 13.9% on the prior year. Free cash flow was $1.36bn. These figures are as reported in the filings, not restated: 30 fiscal years and 121 quarters of history, back to December 1996. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$11.04bn
+11.8%
Net income
$992.0m
+13.9%
Gross margin
33.21%
Free cash flow
$1.36bn
+49.5%
Net debt
$6.50bn
Shares short (30 Oct 2026)
3.73m
3.64 days to cover
Quest Diagnostics Incorporated income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue11.049.879.259.8810.79
Cost of revenue7.376.636.206.456.58
Gross profit3.673.243.053.434.21
Selling, general & admin.1.971.771.801.821.73
Operating income1.561.351.261.432.38
EBITDA2.191.891.261.823.16
Interest expense0.280.230.150.150.15
Pre-tax income1.361.191.131.282.68
Income tax0.310.27-0.250.260.60
Net income0.990.870.850.952.00

Download Quest Diagnostics Incorporated fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.DGX.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 30 fiscal years and 121 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Quest Diagnostics Incorporated

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Quest Diagnostics Incorporated Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Quest Diagnostics Incorporated; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Quest Diagnostics Incorporated’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Quest Diagnostics Incorporated behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Quest Diagnostics Incorporated (United States)

Quest Diagnostics Incorporated is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Digi Power X Inc.

Frequently asked questions

What is Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Quest Diagnostics Incorporated price?
The latest close is 252.92 (1 Nov 2026), +0.03% on the day. The price at the top of the page refreshes during the trading day.
Is Quest Diagnostics Incorporated in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Quest Diagnostics Incorporated?
20-day realised volatility is 20.1% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 5.8% over a month and 2.8% over a week.
What factors affect Quest Diagnostics Incorporated?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Quest Diagnostics Incorporated, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Quest Diagnostics Incorporated?
58 backtested tactical asset allocation strategies trade Quest Diagnostics Incorporated through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Quest Diagnostics Incorporated returns analysed?
The Statistical Distribution of Returns section shows the distribution of Quest Diagnostics Incorporated daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Quest Diagnostics Incorporated historical data?
In the Free historical data section of this page: the last 10 years of Quest Diagnostics Incorporated daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Quest Diagnostics Incorporated historical data (last 10 years)

Browse or instantly download the last 10 years of Quest Diagnostics Incorporated daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.DGX.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20258.28
2026-11-19259.09
2026-11-18259.69
2026-11-17256.35
2026-11-16262.21
2026-11-13259.6
2026-11-12259.65
2026-11-11258.69
2026-11-10258.44
2026-11-09259.67
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.